Trial Profile
A proof-of-concept trial to investigate the effect of low-dose danazol administered intranasally for the treatment of allergic rhinitis.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 19 Oct 2011
Price :
$35
*
At a glance
- Drugs Danazol (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- 19 Oct 2011 New trial record